美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
TOFRANIL	011838	002	NDA	IMIPRAMINE HYDROCHLORIDE	INJECTABLE;INJECTION	12.5MG/ML	No	No	1959/10/02	Approved Prior to Jan 1, 1982	NOVARTIS	Discontinued
TOFRANIL-PM	017090	001	NDA	IMIPRAMINE PAMOATE	CAPSULE;ORAL	EQ 75MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1973/03/11	Approved Prior to Jan 1, 1982	SPECGX LLC	Discontinued
TOFRANIL-PM	017090	002	NDA	IMIPRAMINE PAMOATE	CAPSULE;ORAL	EQ 150MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1973/03/11	Approved Prior to Jan 1, 1982	SPECGX LLC	Discontinued
TOFRANIL-PM	017090	003	NDA	IMIPRAMINE PAMOATE	CAPSULE;ORAL	EQ 125MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1973/03/11	Approved Prior to Jan 1, 1982	SPECGX LLC	Discontinued
TOFRANIL-PM	017090	004	NDA	IMIPRAMINE PAMOATE	CAPSULE;ORAL	EQ 100MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1973/03/11	Approved Prior to Jan 1, 1982	SPECGX LLC	Discontinued
TOFRANIL	087846	001	ANDA	IMIPRAMINE HYDROCHLORIDE	TABLET;ORAL	50MG	Yes	No	1984/05/22	1984/05/22	SPECGX LLC	Discontinued